The results from Phase 1 of the Troculeucel Clinical Trial demonstrated stable/improved outcomes in 90% of subjects, with no drug-related adverse events following troculeucel therapy. Troculeucel ...

Ethris announces promising phase 1 results for ETH47, its mRNA therapy for uncontrolled asthma. The inhaled treatment showed ...

MAXONA Pharmaceuticals has officially emerged from stealth mode, announcing the successful completion of its U.S. Phase 1 ...

Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a public biotech company developing new small molecule therapeutic a ...

For Tammy Gusher Delgado, 56, the decision to join a clinical trial was clear. With a recent multiple sclerosis diagnosis and a clinical trial offering either the study drug or an approved ...

About the Trial TransCode's Phase 1 clinical trial is a multicenter ... is committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics based ...

This approval enables the commencement of a Phase 1 clinical trial, a highly anticipated step ... Dr. David Curiel, co-collaborator on the vector design and Professor of Radiation Oncology at ...

Creative Medical Technology (CELZ) announced initial data from the first cohort of its ongoing Phase 1/2 clinical trial of CELZ-201-DDT, the ...

SAB BIO, a clinical-stage biopharmaceutical company, announced it will host a webinar on January 28, 2025, to present topline data from its Phase 1 clinical trial for SAB-142, a novel treatment ...